Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(17/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Aridis Pharmaceuticals, Inc.
Nov 13, 2019
Aridis Pharmaceuticals Announces Third Quarter 2019 Results
Oct 11, 2019
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Sep 30, 2019
Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology
Sep 27, 2019
Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek(TM) 2019
Sep 27, 2019
Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
Sep 08, 2019
Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019
Sep 03, 2019
Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa
Aug 12, 2019
Aridis Pharmaceuticals Announces Second Quarter 2019 Results
Jul 30, 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology
Jul 19, 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Jun 27, 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
Jun 10, 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
May 14, 2019
Aridis Pharmaceuticals Announces First Quarter 2019 Results
Mar 28, 2019
Aridis Pharmaceuticals Announces 2018 Fourth Quarter and Year-End Financial Results and Business Update
Dec 12, 2018
AR-501 (Cystic Fibrosis) Enrolls First Subject in Phase 1/2a Clinical Trial for Treatment of Chronic Lung Infections in Cystic Fibrosis Patients
Dec 04, 2018
Aridis Expands Research Agreement with the Cystic Fibrosis Foundation and is Awarded FDA Expedited Program Designations
Nov 13, 2018
Aridis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Corporate Overview
Nov 07, 2018
Aridis Pharmaceuticals Announces Publication of Positive AR-301 Phase 1/2a Data in "Intensive Care Medicine" and "The Lancet Respiratory Medicine"
Sep 26, 2018
Aridis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference
Sep 24, 2018
Aridis Pharmaceuticals Strengthens Intellectual Property Portfolio With Additional Broad Patent Coverage For Multiple Product Candidates
‹‹
Page 2
››
Latest News
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
Apr 24, 2024
Novo Oil & Gas II Receives Equity Capital Commitment from EnCap Investments
Apr 24, 2024
Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K
Apr 24, 2024
Ranger Energy Services, Inc. Announces Date for First Quarter 2024 Earnings Conference Call
Apr 24, 2024
Crescent Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024
American States Water Company to Report First Quarter 2024 Results
Apr 24, 2024
Seadrill Announces First Quarter 2024 Earnings Release and Conference Call
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events